Cantor Fitzgerald’s Applied Genetic Technologies Corporation AGTC Stock Holding History

Cantor Fitzgerald’s Portfolio AGTC Stock Details AGTC Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2022 Q4	–	Sell	-20,000	Closed	-$5K	–	891
2022 Q3	$5K	Hold	20,000	–	–	﹤0.01%	748
2022 Q2	$15K	Sell	20,000 -2,339,199	-99%	-$2.09M	﹤0.01%	764
2022 Q1	$2.52M	Buy	+2,359,199	New	+$4.29M	0.19%	121

Cantor Fitzgerald's AGTC Position: Q4 2022 in Review

Cantor Fitzgerald sold out of Applied Genetic Technologies Corporation (AGTC) in Q4 2022, closing a stake of 20,000 shares — an estimated $5K sold.

Cantor Fitzgerald first reported a position in AGTC in Q1 2022 and held it in 3 quarters. The position peaked at $2.52M in Q1 2022. 0 funds tracked by Wall St. Rank hold AGTC as of Q4 2022.

Cantor Fitzgerald reported no remaining Applied Genetic Technologies Corporation position as of Q4 2022 after selling out during the quarter.
Cantor Fitzgerald sold 20,000 Applied Genetic Technologies Corporation shares in Q4 2022, an estimated $5K.
Cantor Fitzgerald first reported a position in Applied Genetic Technologies Corporation in Q1 2022 and held it in 3 quarters.
Cantor Fitzgerald's Applied Genetic Technologies Corporation position peaked at $2.52M in Q1 2022.
0 funds tracked by Wall St. Rank held Applied Genetic Technologies Corporation as of Q4 2022.

Based on Cantor Fitzgerald's 13F filing for Q4 2022, filed 14 Feb 2023.